BioCentury | Oct 7, 2013
Financial News

AnGes MG Inc financial update

...AnGes said that Merrill Lynch Japan Securities requested AnGes acquire and cancel the 12,700 stock acquisition rights outstanding from...
BioCentury | Oct 7, 2013
Finance

Regulatory milestones

...Last month, AnGes canceled its 12,700 remaining stock acquisition rights under a similar deal with Merrill Lynch Japan Securities...
BioCentury | Aug 12, 2013
Financial News

RaQualia completes warrant exercise

...Warrant exercise Raised: ¥271.8 million ($2.8 million) Shares: 290,000 Shares after offering: 13.6 million Investor: Merrill Lynch Japan Securities...
BioCentury | Jul 15, 2013
Financial News

RaQualia completes private placement

...completed: 7/4/13 Type: Private placement Raised: ¥37.4 million ($377,250) Shares outstanding prior: 13.3 million Investor: Merrill Lynch Japan Securities...
BioCentury | Jun 24, 2013
Financial News

RaQualia proposes private placement

...billion ($35 million) Shares: 2.5 million Price prior: ¥1,310 Shares outstanding prior: 13.3 million Investor: Merrill Lynch Japan Securities...
BioCentury | Jun 24, 2013
Finance

Highlights of weekly biotech stock moves

...at least ¥3.3 billion ($34.7 million) through the exercise of 2,500 stock acquisition rights by Merrill Lynch Japan Securities...
BioCentury | Jun 18, 2013
Financial News

RaQualia looks to raise at least $35 million

...at least Y3.3 billion ($34.7 million) through the exercise of 2,500 stock acquisition rights by Merrill Lynch Japan Securities...
BioCentury | May 27, 2013
Financial News

AnGes completes private placement

...placement Raised: ¥1.2 billion ($11.4 million) Shares: 4,000 Price: ¥287,100 Shares after offering: 153,033 Investor: Merrill Lynch Japan Securities...
BioCentury | May 24, 2013
Financial News

AnGes raises $11.2 million

...Japanese gene therapy company AnGes MG Inc. (Tokyo:4563) raised Y1.1 billion ($11.2 million) after Merrill Lynch Japan Securities exercised...
BioCentury | May 13, 2013
Financial News

AnGes proposes private placement

...raised: At least ¥5.1 billion ($51.2 million) Price prior: ¥253,600 Shares outstanding prior: 149,033 Investor: Merrill Lynch Japan Securities...
Items per page:
1 - 10 of 13
BioCentury | Oct 7, 2013
Financial News

AnGes MG Inc financial update

...AnGes said that Merrill Lynch Japan Securities requested AnGes acquire and cancel the 12,700 stock acquisition rights outstanding from...
BioCentury | Oct 7, 2013
Finance

Regulatory milestones

...Last month, AnGes canceled its 12,700 remaining stock acquisition rights under a similar deal with Merrill Lynch Japan Securities...
BioCentury | Aug 12, 2013
Financial News

RaQualia completes warrant exercise

...Warrant exercise Raised: ¥271.8 million ($2.8 million) Shares: 290,000 Shares after offering: 13.6 million Investor: Merrill Lynch Japan Securities...
BioCentury | Jul 15, 2013
Financial News

RaQualia completes private placement

...completed: 7/4/13 Type: Private placement Raised: ¥37.4 million ($377,250) Shares outstanding prior: 13.3 million Investor: Merrill Lynch Japan Securities...
BioCentury | Jun 24, 2013
Financial News

RaQualia proposes private placement

...billion ($35 million) Shares: 2.5 million Price prior: ¥1,310 Shares outstanding prior: 13.3 million Investor: Merrill Lynch Japan Securities...
BioCentury | Jun 24, 2013
Finance

Highlights of weekly biotech stock moves

...at least ¥3.3 billion ($34.7 million) through the exercise of 2,500 stock acquisition rights by Merrill Lynch Japan Securities...
BioCentury | Jun 18, 2013
Financial News

RaQualia looks to raise at least $35 million

...at least Y3.3 billion ($34.7 million) through the exercise of 2,500 stock acquisition rights by Merrill Lynch Japan Securities...
BioCentury | May 27, 2013
Financial News

AnGes completes private placement

...placement Raised: ¥1.2 billion ($11.4 million) Shares: 4,000 Price: ¥287,100 Shares after offering: 153,033 Investor: Merrill Lynch Japan Securities...
BioCentury | May 24, 2013
Financial News

AnGes raises $11.2 million

...Japanese gene therapy company AnGes MG Inc. (Tokyo:4563) raised Y1.1 billion ($11.2 million) after Merrill Lynch Japan Securities exercised...
BioCentury | May 13, 2013
Financial News

AnGes proposes private placement

...raised: At least ¥5.1 billion ($51.2 million) Price prior: ¥253,600 Shares outstanding prior: 149,033 Investor: Merrill Lynch Japan Securities...
Items per page:
1 - 10 of 13